Neurobit Technologies Company

Neurobit uses sleep as a biomarker across age, gender and race to predict and prevent adverse health outcomes well before they happen.

Estimated Revenue: $1M to $10M
Funding Status: Seed
Industry: Artificial Intelligence, Big Data, Fitness, Health Care, Health Diagnostics, Home Health Care, Neuroscience, Personal Health, Wearables, Wellness
Investors Number: 1
Last Funding Date: 2020
Technology: NeuroTech
Founded Date: 2018-05-11
Investor Type: For Profit
Headquarters: Greater New York Area, East Coast, Northeastern US
Total Funding: 298508
Last Funding Type: Grant
Employee Number: 11-50